Great News: GS-441524 Is Now Legally Available!

Since June 2024, GS-441524 is legally available from US compounding pharmacies by veterinary prescription. Oral tablets are now first-line treatment. Ask your vet to prescribe from Stokes Pharmacy, Wedgewood, or other licensed compounding pharmacies.

Over 20,000 cats treated with Bova GS-441524 worldwide. 78–96% survival in clinical studies.

This site is now a read-only archive. FIPLog.com operated 2020–2025. This site no longer accepts new data.
This page contains links to peer-reviewed studies on GS-441524 for FIP treatment. Updated May 2025 with recent legal compounding pharmacy developments.
Key Update (2024–2025): The FDA announced in May 2024 that it will exercise enforcement discretion for GS-441524 compounded by pharmacies under GFI #256. Multiple US compounding pharmacies (Stokes/Bova, Wedgewood, BCP, Avrio, Las Colinas, and others) now offer regulated, quality-tested GS-441524 tablets and oral suspensions. A 2025 Dutch study of 127 cats showed 78% overall survival with legally compounded GS-441524. Over 20,000 cats have been treated with Bova GS-441524 worldwide.

Key Peer-Reviewed Studies

How to Obtain GS-441524 (Updated 2025)
GS-441524 is now legally available in the US! The FDA CVM announced in May 2024 that compounded GS-441524 falls under enforcement discretion (GFI #256). Your veterinarian can prescribe it from licensed compounding pharmacies.
US Compounding Pharmacies Offering GS-441524:

A valid veterinary prescription is required. Contact your veterinarian to discuss FIP diagnosis and treatment.

Treatment Summary
  1. Standard treatment: 84 days (12 weeks) of daily oral GS-441524
  2. Oral tablets/suspension are now first-line (replacing daily injections for most cases)
  3. Dosing by FIP type: Wet 6 mg/kg, Dry 10 mg/kg, Ocular 10 mg/kg, Neurological 10–15 mg/kg
  4. Oral GS has ~50% bioavailability vs injectable, so oral doses are adjusted accordingly
  5. Bloodwork monitoring throughout treatment remains important
  6. 78–96% survival rates in published clinical studies using regulated products
Additional Resources